Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
Cancer
|
August 2, 2024
Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody-drug conjugates-induced interstitial lung disease/pneumonitis: An expert consensus in China
Chunwei Xu, Zhanhong Chen, Yuanli Xia, et al.
Thoracic Cancer
|
October 21, 2022
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor
Wenxian Wang, Qian Wang, Chunwei Xu, et al.
Thoracic Cancer
|
November 29, 2022
Chinese expert consensus on the diagnosis and treatment of HER2-altered non-small cell lung cancer
Shirong Zhang, Wenxian Wang, Chunwei Xu, et al.
Thoracic Cancer
|
September 20, 2022
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China
Chunwei Xu, Lu Si, Wenxian Wang, et al.
Cancer Biology & Medicine
|
April 9, 2025
Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alteration
Huijing Feng, Yang Xia, Wenxian Wang, et al.
Global Medical Genetics
|
February 28, 2024
Expert Consensus on the Diagnosis and Treatment of <i>NRG1/2</i> Gene Fusion Solid Tumors
Chunwei Xu, Qian Wang, Dong Wang, et al.
Global Medical Genetics
|
November 25, 2024
Expert Consensus on the Diagnosis and Treatment of FGFR Gene-Altered Solid Tumors
Chunwei Xu, Bin Lian, Juanjuan Ou, et al.
Innovation (Cambridge (Mass.))
|
November 12, 2024
Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations
Wenxian Wang, Bin Lian, Chunwei Xu, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
Cancer
|
August 2, 2024
Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody-drug conjugates-induced interstitial lung disease/pneumonitis: An expert consensus in China
Chunwei Xu, Zhanhong Chen, Yuanli Xia, et al.
Thoracic Cancer
|
October 21, 2022
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor
Wenxian Wang, Qian Wang, Chunwei Xu, et al.
Thoracic Cancer
|
November 29, 2022
Chinese expert consensus on the diagnosis and treatment of HER2-altered non-small cell lung cancer
Shirong Zhang, Wenxian Wang, Chunwei Xu, et al.
Thoracic Cancer
|
September 20, 2022
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China
Chunwei Xu, Lu Si, Wenxian Wang, et al.
Cancer Biology & Medicine
|
April 9, 2025
Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alteration
Huijing Feng, Yang Xia, Wenxian Wang, et al.
Global Medical Genetics
|
February 28, 2024
Expert Consensus on the Diagnosis and Treatment of <i>NRG1/2</i> Gene Fusion Solid Tumors
Chunwei Xu, Qian Wang, Dong Wang, et al.
Global Medical Genetics
|
November 25, 2024
Expert Consensus on the Diagnosis and Treatment of FGFR Gene-Altered Solid Tumors
Chunwei Xu, Bin Lian, Juanjuan Ou, et al.
Innovation (Cambridge (Mass.))
|
November 12, 2024
Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations
Wenxian Wang, Bin Lian, Chunwei Xu, et al.
Page
of 4